Ciaramella, Vincenza
Sasso, Ferdinando Carlo
Di Liello, Raimondo
Corte, Carminia Maria Della
Barra, Giusi
Viscardi, Giuseppe
Esposito, Giovanna
Sparano, Francesca
Troiani, Teresa
Martinelli, Erika
Orditura, Michele
De Vita, Ferdinando
Ciardiello, Fortunato
Morgillo, Floriana
Article History
Received: 11 January 2019
Accepted: 14 April 2019
First Online: 26 April 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Fortunato Ciardiello: Advisory Boards: Roche, Amgen, Merck, Pfizer, Sanofi, Bayer, Servier, BMS, Cellgene, Lilly; Institutional Research Grants: Bayer, Roche, Merck, Amgen, AstraZeneca, Ipsen.FlorianaMorgillo: Advisory Boards MSD, Lilly; Institutional Research Grants: AstraZeneca.Ferdinando De Vita: Advisory Board: Lilly, Celgene, Roche, Amgen.Michele Orditura: Advisory Board: Roche, Epionpharma-Italfarmaco, Eisai.All other coauthors have no conflicts of interest to declare for the following manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.